Editas Medicine (EDIT) Total Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Current Liabilities data on file, last reported at $46.2 million in Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 40.12% year-over-year to $46.2 million in Q4 2025; TTM through Dec 2025 was $46.2 million, a 40.12% decrease from a year earlier, with the FY2025 full-year figure at $46.2 million, down 40.12% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $46.2 million, down from $61.8 million in the prior quarter.
• Over the last five years, Total Current Liabilities for EDIT reached as high as $77.2 million in Q4 2024 and fell as low as $36.4 million in Q2 2022.
• Historically, Total Current Liabilities has averaged $58.7 million across 5 years, with a median of $60.9 million in 2022.
• Across the five-year window, Total Current Liabilities tumbled 44.83% in 2022 and soared 56.58% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $46.9 million in 2021, then climbed by 28.21% to $60.1 million in 2022, then increased by 5.17% to $63.2 million in 2023, then rose by 22.16% to $77.2 million in 2024, then slumped by 40.12% to $46.2 million in 2025.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $46.2 million in Q4 2025, $61.8 million in Q3 2025, and $65.9 million in Q2 2025.